Hypopharynx Cancer Clinical Trials in New York, New York
2 recruitingNew York, New York
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Squamous Cell Carcinoma of Head and NeckOral Cavity CancerNasal Cavity Cancer+9 more
Memorial Sloan Kettering Cancer Center40 enrolled7 locationsNCT07063212
Recruiting
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
HNSCCOral Cavity CancerOropharynx Cancer+2 more
University Hospital Freiburg1,500 enrolled18 locationsNCT05337631